<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32614521</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1582-4934</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>15</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cellular and molecular medicine</Title>
          <ISOAbbreviation>J Cell Mol Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice.</ArticleTitle>
        <Pagination>
          <StartPage>8391</StartPage>
          <EndPage>8404</EndPage>
          <MedlinePgn>8391-8404</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/jcmm.15332</ELocationID>
        <Abstract>
          <AbstractText>Mindin is important in broad spectrum of immune responses. On the other hand, we previously reported that mindin attenuated human colon cancer development by blocking angiogenesis through Egr-1-mediated regulation. However, the mice original mindin directly suppressed the syngenic colorectal cancer (CRC) growth in our recent study and we aimed to further define the role of mindin during CRC development in mice. We established the mouse syngeneic CRC CMT93 and CT26 WT cell lines with stable mindin knock-down or overexpression. These cells were also subcutaneously injected into C57BL/6 and BALB/c mice as well as established a colitis-associated colorectal cancer (CAC) mouse model treated with lentiviral-based overexpression and knocked-down of mindin. Furthermore, we generated mindin knockout mice using a CRISPR-Cas9 system with CAC model. Our data showed that overexpression of mindin suppressed cell proliferation in both of CMT93 and CT26 WT colon cancer cell lines, while the silencing of mindin promoted in vitro cell proliferation via the ERK and c-Fos pathways and cell cycle control. Moreover, the overexpression of mindin significantly suppressed in vivo tumour growth in both the subcutaneous transplantation and the AOM/DSS-induced CAC models. Consistently, the silencing of mindin reversed these in vivo observations. Expectedly, the tumour growth was promoted in the CAC model on mindin-deficient mice. Thus, mindin plays a direct tumour suppressive function during colon cancer progression and suggesting that mindin might be exploited as a therapeutic target for CRC.</AbstractText>
          <CopyrightInformation>© 2020 Zhongshan Hospital affiliated to Xiamen University, China. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Xiao-Shen</ForeName>
            <Initials>XS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huo</LastName>
            <ForeName>Ya-Ni</ForeName>
            <Initials>YN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Yan-Yun</ForeName>
            <Initials>YY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiao</LastName>
            <ForeName>Chuan-Xing</ForeName>
            <Initials>CX</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ouyang</LastName>
            <ForeName>Xiao-Mei</ForeName>
            <Initials>XM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Lai-Ying</ForeName>
            <Initials>LY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Jian-Feng</ForeName>
            <Initials>JF</Initials>
            <AffiliationInfo>
              <Affiliation>School of Life Sciences, Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Jian-Lin</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guleng</LastName>
            <ForeName>Bayasi</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0003-1106-5304</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Cancer Research Center &amp; Institute of Microbial Ecology, Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Cellular Stress Biology, Xiamen University, Xiamen, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>07</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Cell Mol Med</MedlineTA>
        <NlmUniqueID>101083777</NlmUniqueID>
        <ISSNLinking>1582-1838</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016326">Extracellular Matrix Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C000708711">Spon2 protein, mouse</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003092" MajorTopicYN="N">Colitis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003110" MajorTopicYN="N">Colonic Neoplasms</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016326" MajorTopicYN="N">Extracellular Matrix Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016147" MajorTopicYN="N">Genes, Tumor Suppressor</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067996" MajorTopicYN="N">RAW 264.7 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">MAPK/ERK</Keyword>
        <Keyword MajorTopicYN="Y">colorectal cancer</Keyword>
        <Keyword MajorTopicYN="Y">mindin</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32614521</ArticleId>
        <ArticleId IdType="pmc">PMC7412704</ArticleId>
        <ArticleId IdType="doi">10.1111/jcmm.15332</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43‐66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17237035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gustavsson B. Simultaneous surgery for primary colorectal cancer and metastatic lesions?
Scand J Gastroenterol. 2011;47(3):269‐276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22242554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stec R, Bodnar L, Charkiewicz R, et al. K‐Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan‐ or oxaliplatin‐based chemotherapy. Cancer Biol Ther. 2012;13(13):1235‐1243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3493430</ArticleId>
            <ArticleId IdType="pubmed">22909976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Curia MC, De Iure S, De Lellis L, et al. Increased variance in germline allele‐specific expression of APC associates with colorectal cancer. Gastroenterology. 2012;142(1):71‐77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3246305</ArticleId>
            <ArticleId IdType="pubmed">21995949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mattick JS, Makunin IV. Non‐coding RNA. Human Mol Genet. 2006;15(suppl_1):R17‐R29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16651366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hardy RG, Meltzer SJ, Jankowski JA. ABC of colorectal cancer. Molecular basis for risk factors. BMJ. 2000;321(7265):886‐889.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1118685</ArticleId>
            <ArticleId IdType="pubmed">11021873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646‐674.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21376230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Quante M, Varga J, Wang TC, et al. The gastrointestinal tumor microenvironment. Gastroenterology. 2013;145(1):63‐78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4012393</ArticleId>
            <ArticleId IdType="pubmed">23583733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Geiger B, Bershadsky A. Exploring the neighborhood: adhesion‐coupled cell mechanosensors. Cell. 2002;110(2):139‐142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12150922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Geiger B, Bershadsky A, Pankov R, et al. Transmembrane crosstalk between the extracellular matrix and the cytoskeleton. Nat Rev Mol Cell Biol. 2001;2(11):793‐805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11715046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Adams JC, Tucker RP. The thrombospondin type 1 repeat (TSR) superfamily: diverse proteins with related roles in neuronal development. Dev Dyn. 2000;218(2):280‐299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10842357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Feinstein Y, Borrell V, Garcia C, et al. F‐spondin and mindin: two structurally and functionally related genes expressed in the hippocampus that promote outgrowth of embryonic hippocampal neurons. Development. 1999;126(16):3637‐3648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10409509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Higashijima S‐I, Nose A, Eguchi G, et al. Mindin/F‐spondin family: novel ECM proteins expressed in the zebrafish embryonic axis. Dev Biol. 1997;192(2):211‐227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9441663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li Y, Cao C, Jia W, et al. Structure of the F‐spondin domain of mindin, an integrin ligand and pattern recognition molecule. EMBO J. 2009;28(3):286‐297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2637340</ArticleId>
            <ArticleId IdType="pubmed">19153605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jia W, Li H, He YW. Pattern recognition molecule mindin promotes intranasal clearance of influenza viruses. J Immunol. 2008;180(9):6255‐6261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18424748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
He Y‐W, Li H, Zhang J, et al. The extracellular matrix protein mindin is a pattern‐recognition molecule for microbial pathogens. Nat Immunol. 2003;5(1):88‐97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14691481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li H, Oliver T, Jia W, et al. Efficient dendritic cell priming of T lymphocytes depends on the extracellular matrix protein mindin. EMBO J. 2006;25(17):4097‐4107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1560362</ArticleId>
            <ArticleId IdType="pubmed">16917498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jia W, Li H, He Y‐W. The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment. Blood. 2005;106(12):3854‐3859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1895097</ArticleId>
            <ArticleId IdType="pubmed">16105980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu YS, Wang LF, Cheng XS, et al. The pattern‐recognition molecule mindin binds integrin Mac‐1 to promote macrophage phagocytosis via Syk activation and NF‐kappaB p65 translocation. J Cell Mol Med. 2019;23(5):3402‐3416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6484411</ArticleId>
            <ArticleId IdType="pubmed">30869196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guleng B, Lian YM, Ren JL. Mindin is upregulated during colitis and may activate NF‐kappaB in a TLR‐9 mediated manner. World J Gastroenterol. 2010;16(9):1070‐1075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2835782</ArticleId>
            <ArticleId IdType="pubmed">20205276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sun P, Zhang P, Wang P‐X, et al. Mindin deficiency protects the liver against ischemia/reperfusion injury. J Hepatol. 2015;63(5):1198‐1211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26165142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhu LH, Wang A, Luo P, et al. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator‐activated receptor alpha in mice. J Hepatol. 2014;60(5):1046‐1054.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24445216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Murakoshi M, Tanimoto M, Gohda T, et al. Mindin: a novel marker for podocyte injury in diabetic nephropathy. Nephrol Dial Transpl. 2011;26(7):2153‐2160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21098016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Schmid F, Wang Q, Huska MR, et al. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival. Oncogene. 2016;35(46):5942‐5952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26686083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang Y‐L, Li Q, Yang X‐M, et al. SPON2 promotes M1‐like macrophage recruitment and inhibits hepatocellular carcinoma metastasis by distinct integrin‐rho GTPase–hippo pathways. Cancer Res. 2018;78(9):2305‐2317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29440144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang L‐F, Liu Y‐S, Yang B, et al. The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr‐1‐mediated regulation. Oncogene. 2017;37(5):601‐615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28991232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Feinstein Y, Klar A. The neuronal class 2 TSR proteins F‐spondin and Mindin: a small family with divergent biological activities. Int J Biochem Cell Biol. 2004;36(6):975‐980.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15094111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging‐like phenotype in the absence of mammalian SIRT6. Cell. 2006;124(2):315‐329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16439206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012;13(4):225‐238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4872805</ArticleId>
            <ArticleId IdType="pubmed">22395773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kanfi Y, Naiman S, Amir G, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012;483(7388):218‐221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22367546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang W, Wan H, Feng G, et al. SIRT6 deficiency results in developmental retardation in cynomolgus monkeys. Nature. 2018;560(7720):661‐665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30135584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
McJunkin K, Mazurek A, Premsrirut PK, et al. Reversible suppression of an essential gene in adult mice using transgenic RNA interference. Proc Natl Acad Sci USA. 2011;108(17):7113‐7118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3084121</ArticleId>
            <ArticleId IdType="pubmed">21482754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dickins RA, McJunkin K, Hernando E, et al. Tissue‐specific and reversible RNA interference in transgenic mice. Nat Genet. 2007;39(7):914‐921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4595852</ArticleId>
            <ArticleId IdType="pubmed">17572676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Achyut BR, Yang L. Transforming growth factor‐β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011;141(4):1167‐1178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6644047</ArticleId>
            <ArticleId IdType="pubmed">21839702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Arendt BK, Walters DK, Wu X, et al. Increased expression of extracellular matrix metalloproteinase inducer (CD147) in multiple myeloma: role in regulation of myeloma cell proliferation. Leukemia. 2012;26(10):2286‐2296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3915875</ArticleId>
            <ArticleId IdType="pubmed">22460757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Buchheit CL, Rayavarapu RR, Schafer ZT. The regulation of cancer cell death and metabolism by extracellular matrix attachment. Semin Cell Dev Biol. 2012;23(4):402‐411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22579674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Coulson‐Thomas VJ, Gesteira TF, Coulson‐Thomas YM, et al. Fibroblast and prostate tumor cell cross‐talk: fibroblast differentiation, TGF‐β, and extracellular matrix down‐regulation. Exp Cell Res. 2010;316(19):3207‐3226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20727350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Parry R, Schneider D, Hudson D, et al. Identification of a novel prostate tumor target, mindin/RG‐1, for antibody‐based radiotherapy of prostate cancer. Cancer Res. 2005;65(18):8397‐8405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16166318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Manda R, Kohno T, Matsuno Y, et al. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. Genomics. 1999;61(1):5‐14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10512675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhu L‐H, Huang L, Zhang X, et al. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation. Clin Sci. 2015;129(2):129‐145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25751394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tan K, Lawler J. The structure of the Ca2+‐binding, glycosylated F‐spondin domain of F‐spondin – a C2‐domain variant in an extracellular matrix protein. BMC Struct Biol. 2011;11(1):22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3117680</ArticleId>
            <ArticleId IdType="pubmed">21569239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yan L, Wei X, Tang Q‐Z, et al. Cardiac‐specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF‐β1–Smad signalling. Cardiovasc Res. 2011;92(1):85‐94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3657538</ArticleId>
            <ArticleId IdType="pubmed">21632881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang Q, Wang X‐Q, Wang J, et al. Upregulation of spondin‐2 predicts poor survival of colorectal carcinoma patients. Oncotarget. 2015;6(17):15095‐15110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4558138</ArticleId>
            <ArticleId IdType="pubmed">25945835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Qin M, Ma L‐Q, Tan J, et al. Risk factors for colorectal neoplasms based on colonoscopy and pathological diagnoses of Chinese citizens: a multicenter, case‐control study. Int J Colorectal Dis. 2015;30(3):353‐361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25518811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jing F, Mao Y, Zhang Z, et al. The association of phosphatase and tensin homolog deleted on chromosome 10 polymorphisms and lifestyle habits with colorectal cancer risk in a Chinese population. Tumour Biol. 2014;35(9):9233‐9240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24935469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang M, Zhao QC, Liu YP, et al. Prognostic analysis and comparison of colon cancer in Han and Hui patients. World J Gastroenterol. 2014;20(17):5082‐5086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4009544</ArticleId>
            <ArticleId IdType="pubmed">24803822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Seshagiri S, Stawiski EW, Durinck S, et al. Recurrent R‐spondin fusions in colon cancer. Nature. 2012;488(7413):660‐664.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3690621</ArticleId>
            <ArticleId IdType="pubmed">22895193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3(11):991‐998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12407406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 2011;331(6024):1565‐1570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21436444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kumaran V, Joseph B, Benten D, et al. Integrin and extracellular matrix interactions regulate engraftment of transplanted hepatocytes in the rat liver. Gastroenterology. 2005;129(5):1643‐1653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16285962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yan Y‐X, Gong Y‐W, Guo Y, et al. Mechanical strain regulates osteoblast proliferation through integrin‐mediated ERK activation. PLoS ONE. 2012;7(4):e35709.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3335094</ArticleId>
            <ArticleId IdType="pubmed">22539993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Edick MJ, Tesfay L, Lamb LE, et al. Inhibition of integrin‐mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase‐independent death. Mol Biol Cell. 2007;18(7):2481‐2490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1924805</ArticleId>
            <ArticleId IdType="pubmed">17475774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shakibaei M, Mobasheri A, Lueders C, et al. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF‐κB and Src protein kinase signaling pathways. PLoS ONE. 2013;8(2):e57218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3579779</ArticleId>
            <ArticleId IdType="pubmed">23451189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Suen KM, Lin C‐C, George R, et al. Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli. Nat Struct Mol Biol. 2013;20(5):620‐627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4059177</ArticleId>
            <ArticleId IdType="pubmed">23584453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hasegawa M, Kondo M, Suzuki I, et al. ERK is involved in tooth‐pressure‐induced Fos Expression in Vc neurons. J Dent Res. 2012;91(12):1141‐1146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23018815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Qian X, Li C, Pang BO, et al. Spondin‐2 (SPON2), a more prostate‐cancer‐specific diagnostic biomarker. PLoS ONE. 2012;7(5):e37225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3352876</ArticleId>
            <ArticleId IdType="pubmed">22615945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Simon I, Liu Y, Krall KL, et al. Evaluation of the novel serum markers B7–H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer. Gynecol Oncol. 2007;106(1):112‐118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17490732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chandrasinghe P, Stebbing J, Warusavitarne J. The MACC1‐SPON2 axis: a new biomarker and therapeutic target in colorectal cancer. Oncogene. 2017;36(11):1474‐1475.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27669439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39‐51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4994190</ArticleId>
            <ArticleId IdType="pubmed">20371344</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
